Cryptosporidium enteritis in solid organ transplant recipients: Multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations

Transplant Infectious Disease

Volumn 14, Issue 6, 2012, Pages 635-648

  Bonatti, H ^a   Barroso Ii, L F ^a   Sawyer, R G ^a   Kotton, C N ^b   Sifri, C D ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cryptosporidiosis; Cryptosporidium; Diarrhea; Enteritis; Infection; Parasitic infection; Tacrolimus toxicity; Transplantation

Indexed keywords

TACROLIMUS;

ADULT; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; CRYPTOSPORIDIOSIS; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT;

ADULT; CRYPTOSPORIDIOSIS; ENTERITIS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; TACROLIMUS;

EID: 84871019611     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2012.00719.x     Document Type: Article

References (90)

1. Stelzmueller I, Wiesmayr S, Swenson BR, et al. Rotavirus enteritis in solid organ transplant recipients: an underestimated problem? Transpl Infect Dis 2007; 9 (4): 281-285.
2. Stelzmueller I, Goegele H, Biebl M, et al. Clostridium difficile colitis in solid organ transplantation-a single-center experience. Dig Dis Sci 2007; 52 (11): 3231-3236.
3. Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl 2005; 11 (8): 881-890.
4. Stelzmueller I, Dunst KM, Hengster P, et al. A cluster of rotavirus enteritis in adult transplant recipients. Transpl Int 2005; 18 (4): 470-474.
5. Westhoff TH, Vergoulidou M, Loddenkemper C, et al. Chronic norovirus infection in renal transplant recipients. Nephrol Dial Transplant 2009; 24 (3): 1051-1053.
6. Albright JB, Bonatti H, Mendez J, et al. Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int 2007; 20 (10): 856-866.
7. Gellad ZF, Alexander BD, Liu JK, et al. Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients. Transpl Infect Dis 2007; 9 (4): 276-280.
8. Keven K, Basu A, Re L, et al. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis 2004; 6 (1): 10-14.
9. Arslan H, Inci EK, Azap OK, Karakayali H, Torgay A, Haberal M. Etiologic agents of diarrhea in solid organ recipients. Transpl Infect Dis 2007; 9 (4): 270-275.
10. White AC Jr. Cryptosporidium species. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and Practice of Infectious Diseases. (7th edn.) Philadelphia: Churchill Livingstone Elselvier, 2010: 3547-3560.
11. Clark DP, Sears CL. The pathogenesis of cryptosporidiosis. Parasitol Today 1996; 12 (6): 221-225.
12. Mac Kenzie WR, Hoxie NJ, Proctor ME, et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994; 331 (3): 161-167.
13. Communitywide cryptosporidiosis outbreak-Utah, 2007. MMWR Morb Mortal Wkly Rep 2008; 57 (36): 989-993.
14. Goldstein ST, Juranek DD, Ravenholt O, et al. Cryptosporidiosis: an outbreak associated with drinking water despite state-of-the-art water treatment. Ann Intern Med 1996; 124 (5): 459-468.
15. Semenza JC, Nichols G. Cryptosporidiosis surveillance and water-borne outbreaks in Europe. Euro Surveill 2007; 12 (5): E13-E14.
16. Yoder JS, Harral C, Beach MJ. Cryptosporidiosis surveillance - United States, 2006-2008. MMWR Surveill Summ 2010; 59 (6): 1-14.
17. Vakil NB, Schwartz SM, Buggy BP, et al. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 1996; 334 (1): 19-23.
18. Campos M, Jouzdani E, Sempoux C, et al. Sclerosing cholangitis associated to cryptosporidiosis in liver-transplanted children. Eur J Pediatr 2000; 159 (1-2): 113-115.
19. Denkinger CM, Harigopal P, Ruiz P, Dowdy LM. Cryptosporidium parvum-associated sclerosing cholangitis in a liver transplant patient. Transpl Infect Dis 2008; 10 (2): 133-136.
20. Newman RD, Sears CL, Moore SR, et al. Longitudinal study of Cryptosporidium infection in children in northeastern Brazil. J Infect Dis 1999; 180 (1): 167-175.
21. Agnew DG, Lima AA, Newman RD, et al. Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J Infect Dis 1998; 177 (3): 754-760.
22. Burdese M, Veglio V, Consiglio V, et al. A dance teacher with kidney-pancreas transplant and diarrhoea: what is the cause? Nephrol Dial Transplant 2005; 20 (8): 1759-1761.
23. Delis SG, Tector J, Kato T, et al. Diagnosis and treatment of Cryptosporidium infection in intestinal transplant recipients. Transplant Proc 2002; 34 (3): 951-952.
24. Franco A, Rocamora N, Merino E, Paya A. [Cryptosporidiosis. A rare infection in renal transplantation.] Nefrologia 2006; 26 (6): 753-754.
25. Gasink LB, Seymour C, Blumberg EA, Goldberg LR, Fishman NO. An uncommon presentation of an uncommon disease: leprosy in a heart transplant recipient. J Heart Lung Transplant 2006; 25 (7): 854-856.
26. Hong DK, Wong CJ, Gutierrez K. Severe cryptosporidiosis in a seven-year-old renal transplant recipient: case report and review of the literature. Pediatr Transplant 2007; 11 (1): 94-100.
27. Chieffi PP, Sens YA, Paschoalotti MA, Miorin LA, Silva HG, Jabur P. Infection by Cryptosporidium parvum in renal patients submitted to renal transplant or hemodialysis. Rev Soc Bras Med Trop 1998; 31 (4): 333-337.
28. Kaushik K, Khurana S, Wanchu A, Malla N. Lymphoproliferative and cytokine responses to Cryptosporidium parvum in patients coinfected with C. parvum and human immunodeficiency virus. Clin Vaccine Immunol 2009; 16 (1): 116-121.
29. Khalil-ur R, Al-Amoudi A, Badreddine S, Al-Shehri AM, Kanaan H, Al-Ghamdi SM. Cryptosporidiosis in a renal transplant patient treated with paromomycin. Ann Saudi Med 2007; 27 (5): 373-374.
30. Minz M, Udgiri NK, Heer MK, Kashyap R, Malla N. Cryptosporidiasis in live related renal transplant recipients: a single center experience. Transplantation 2004; 77 (12): 1916-1917.
31. Ok UZ, Cirit M, Uner A, et al. Cryptosporidiosis and blastocystosis in renal transplant recipients. Nephron 1997; 75 (2): 171-174.
32. Perez C, Mocarquer A, Morales J, et al. [Parasitic infections in renal transplantation patients.] Rev Med Chil 1989; 117 (9): 997-1001.
33. Roncoroni AJ, Gomez MA, Mera J, Cagnoni P, Michel MD. Cryptosporidium infection in renal transplant patients. J Infect Dis 1989; 160 (3): 559.
34. Sanad MM, Al-Malki JS. Cryptosporidiosis among immunocompromised patients in Saudi Arabia. J Egypt Soc Parasitol 2007; 37 (Suppl 2): 765-774.
35. Udgiri N, Minz M, Kashyap R, et al. Intestinal cryptosporidiasis in living related renal transplant recipients. Transplant Proc 2004; 36 (7): 2128-2129.
36. Gerber DA, Green M, Jaffe R, Greenberg D, Mazariegos G, Reyes J. Cryptosporidial infections after solid organ transplantation in children. Pediatr Transplant 2000; 4 (1): 50-55.
37. Pozio E, Rivasi F, Caccio SM. Infection with Cryptosporidium hominis and reinfection with Cryptosporidium parvum in a transplanted ileum. APMIS 2004; 112 (4-5): 309-313.
38. Ziring D, Tran R, Edelstein S, et al. Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation 2005; 79 (6): 702-709.
39. Bandin F, Kwon T, Linas MD, et al. Cryptosporidiosis in paediatric renal transplantation. Pediatr Nephrol 2009; 24 (11): 2245-2255.
40. Metzger R, Swenson BR, Bonatti H, et al. Identification of risk factors for the development of Clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infections. Ann Surg 2010; 251 (4): 722-727.
41. Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 2010; 363 (21): 2004-2014.
42. Cook TD, Campbell DT. Quasi-Experimentation: Design & Analysis Issues for Field Settings. Boston: Houghton Mifflin, 1979.
43. Ringden O, Soderdahl G, Mattsson J, et al. Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer. Transplantation 2000; 69 (10): 2043-2048.
44. Weisburger WR, Hutcheon DF, Yardley JH, Roche JC, Hillis WD, Charache P. Cryptosporidiosis in an immunosuppressed renal-transplant recipient with IgA deficiency. Am J Clin Pathol 1979; 72 (3): 473-478.
45. Bjoro K, Schrumpf E, Bergan A, Haaland T, Skaug K, Froland SS. Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia. Scand J Infect Dis 1998; 30 (5): 520-522.
46. Abdo A, Klassen J, Urbanski S, Raber E, Swain MG. Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patient. J Hepatol 2003; 38 (5): 688-691.
47. Kaushik K, Khurana S, Wanchu A, Malla N. Serum immunoglobulin G, M and A response to Cryptosporidium parvum in Cryptosporidium-HIV co-infected patients. BMC Infect Dis 2009; 9: 179.
48. Clifford CP, Crook DW, Conlon CP, Fraise AP, Day DG, Peto TE. Impact of waterborne outbreak of cryptosporidiosis on AIDS and renal transplant patients. Lancet 1990; 335 (8703): 1455-1456.
49. Vajro P, di Martino L, Scotti S, Barbati C, Fontanella A, Pettoello Mantovani M. Intestinal Cryptosporidium carriage in two liver-transplanted children. J Pediatr Gastroenterol Nutr 1991; 12 (1): 139.
50. Ditrich O, Palkovic L, Sterba J, Prokopic J, Loudova J, Giboda M. The first finding of Cryptosporidium baileyi in man. Parasitol Res 1991; 77 (1): 44-47.
51. Kausman JY, Somers GR, Francis DM, Jones CL. Association of renal adenocarcinoma and BK virus nephropathy post transplantation. Pediatr Nephrol 2004; 19 (4): 459-462.
52. Dumortier J, Cruchaudet B, Piens MA, Bouffard Y, Peyregne V, Boillot O. [Cryptosporidiosis after liver transplantation.] Gastroenterol Clin Biol 2005; 29 (11): 1186-1187.
53. Tran MQ, Gohh RY, Morrissey PE, et al. Cryptosporidium infection in renal transplant patients. Clin Nephrol 2005; 63 (4): 305-309.
54. Manz M, Steuerwald M. Cryptosporidiosis in a patient on PEG-interferon and ribavirin for recurrent hepatitis C after living donor liver transplantation. Transpl Infect Dis 2007; 9 (1): 60-61.
55. Rodriguez Ferrero ML, Munoz P, Valerio M, Bouza E, Martin-Rabadan P, Anaya F. [Cryptosporidium parvum infection in a kidney transplant recipient.] Nefrologia 2010; 30 (4): 476-477.
56. Frei P, Weber A, Geier A, et al. Lessons from a transplant patient with diarrhea, cryptosporidial infection, and possible mycophenolate mofetil-associated colitis. Transpl Infect Dis 2011; 13 (4): 416-418.
57. Fruhwirth M, Fischer H, Simma B, et al. Rotavirus infection as cause of tacrolimus elevation in solid-organ-transplanted children. Pediatr Transplant 2001; 5 (2): 88-92.
58. Berengue JI, Lopez-Espinosa JA, Ortega-Lopez J, et al. Two- to three-fold increase in blood tacrolimus (FK506) levels during diarrhea in liver-transplanted children. Clin Transplant 2003; 17 (3): 249-253.
59. Asano T, Nishimoto K, Hayakawa M. Increased tacrolimus trough levels in association with severe diarrhea, a case report. Transplant Proc 2004; 36 (7): 2096-2097.
60. Eades SK, Boineau FG, Christensen ML. Increased tacrolimus levels in a pediatric renal transplant patient attributed to chronic diarrhea. Pediatr Transplant 2000; 4 (1): 63-66.
61. Hochleitner BW, Bosmuller C, Nehoda H, et al. Increased tacrolimus levels during diarrhea. Transpl Int 2001; 14 (4): 230-233.
62. Venkataramanan R, Swaminathan A, Prasad T, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 1995; 29 (6): 404-430.
63. Lampen A, Christians U, Gonschior AK, et al. Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber. Br J Pharmacol 1996; 117 (8): 1730-1734.
64. Watanabe Y, Sato M, Abe Y, et al. Enteric absorption of FK 506: estimation by a block liver perfusion technique in rats. Transplant Proc 1998; 30 (7): 3777-3778.
65. Kaplan B, Lown K, Craig R, et al. Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity. Transplantation 1999; 67 (2): 333-335.
66. Kolars JC, Lown KS, Schmiedlin-Ren P, et al. CYP3A gene expression in human gut epithelium. Pharmacogenetics 1994; 4 (5): 247-259.
67. Novelli M, Muiesan P, Mieli-Vergani G, Dhawan A, Rela M, Heaton ND. Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel. Transpl Int 1999; 12 (6): 463-465.
68. Maezono S, Sugimoto K, Sakamoto K, et al. Elevated blood concentrations of calcineurin inhibitors during diarrheal episode in pediatric liver transplant recipients: involvement of the suppression of intestinal cytochrome P450 3A and P-glycoprotein. Pediatr Transplant 2005; 9 (3): 315-323.
69. Zahir H, McCaughan G, Gleeson M, Nand RA, McLachlan AJ. Factors affecting variability in distribution of tacrolimus in liver transplant recipients. Br J Clin Pharmacol 2004; 57 (3): 298-309.
70. Zahir H, Nand RA, Brown KF, Tattam BN, McLachlan AJ. Validation of methods to study the distribution and protein binding of tacrolimus in human blood. J Pharmacol Toxicol Methods 2001; 46 (1): 27-35.
71. Abu-Elmagd K, Fung JJ, Alessiani M, et al. The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation 1991; 52 (1): 71-77.
72. Bekersky I, Dressler D, Alak A, Boswell GW, Mekki QA. Comparative tacrolimus pharmacokinetics: normal versus mildly hepatically impaired subjects. J Clin Pharmacol 2001; 41 (6): 628-635.
73. Jain AB, Venkataramanan R, Cadoff E, et al. Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc 1990; 22 (1): 57-59.
74. Stelzmueller I, Wiesmayr S, Eller M, et al. Enterocolitis due to simultaneous infection with rotavirus and Clostridium difficile in adult and pediatric solid organ transplantation. J Gastrointest Surg 2007; 11 (7): 911-917.
75. Mori T, Aisa Y, Nakazato T, Yamazaki R, Ikeda Y, Okamoto S. Tacrolimus-azithromycin interaction in a recipient of allogeneic bone marrow transplantation. Transpl Int 2005; 18 (6): 757-758.
76. Amacher DE, Schomaker SJ, Retsema JA. Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. Antimicrob Agents Chemother 1991; 35 (6): 1186-1190.
77. Paterson DL, Singh N. Interactions between tacrolimus and antimicrobial agents. Clin Infect Dis 1997; 25 (6): 1430-1440.
78. Peters DH, Fitton A, Plosker GL, Faulds D. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs 1993; 46 (4): 746-794.
79. Wallemacq PE, Reding R. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. Clin Chem 1993; 39 (11 Pt 1): 2219-2228.
80. Prograf (Tacrolimus) Package Insert. Deerfield, IL: Astellas Pharma US, Inc, 2006.
81. Kotton CN, Hibberd PL. Travel medicine and the solid organ transplant recipient. Am J Transplant 2009; 9 (Suppl 4): S273-S281.
82. Osewe P, Addiss DG, Blair KA, Hightower A, Kamb ML, Davis JP. Cryptosporidiosis in Wisconsin: a case-control study of post-outbreak transmission. Epidemiol Infect 1996; 117 (2): 297-304.
83. Werneck-Silva AL, Prado IB. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of highly active antiretroviral therapy. J Gastroenterol Hepatol 2009; 24 (1): 135-139.
84. Gautam H, Bhalla P, Saini S, et al. Epidemiology of opportunistic infections and its correlation with CD4 T-lymphocyte counts and plasma viral load among HIV-positive patients at a tertiary care hospital in India. J Int Assoc Physicians AIDS Care (Chic) 2009; 8 (6): 333-337.
85. Inungu JN, Morse AA, Gordon C. Risk factors, seasonality, and trends of cryptosporidiosis among patients infected with human immunodeficiency virus. Am J Trop Med Hyg 2000; 62 (3): 384-387.
86. Sorvillo FJ, Lieb LE, Kerndt PR, Ash LR. Epidemiology of cryptosporidiosis among persons with acquired immunodeficiency syndrome in Los Angeles County. Am J Trop Med Hyg 1994; 51 (3): 326-331.
87. Pedersen C, Danner S, Lazzarin A, et al. Epidemiology of cryptosporidiosis among European AIDS patients. Genitourin Med 1996; 72 (2): 128-131.
88. Navin TR, Weber R, Vugia DJ, et al. Declining CD4 + T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3-year longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20 (2): 154-159.
89. Manabe YC, Clark DP, Moore RD, et al. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis 1998; 27 (3): 536-542.
90. Kotton CN, Lattes R. Parasitic infections in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S234-S251.